Harpoon Therapeutics
在场
Harpoon Therapeutics 是一家在股票代码 HARP (US) 下上市的公司。
高管
查看带有其 18 名主要高管的组织结构图
Harpoon Therapeutics 搜索最多的简介
- Julie Eastland, Director and Chief Executive Officer
- Mark Chin, Director
- Scott Myers, Chairman of the Board
高管在Harpoon Therapeutics变化
- Wendy Chang 曾任 Senior Vice President, Human Resources, 现升职为 Chief People Officer (新闻发布的2023十二月27号).
- James Bucher已作为Chief Legal Officer加入公司 (新闻发布的2023十二月27号).
创建提醒
跟踪 Harpoon Therapeutics 的高管变动
生物技术
Harpoon Therapeutics 拥有 2,293 家竞争者，其中包括 Lonza (瑞士)、Eurofins (卢森堡) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Merck has announced the acquisition of EyeBio (公布2024五月31号).
- Actuate Therapeutics 刚刚宣布为 50 筹款数百万美元。 (公布2024五月29号).
- Grey Wolf Therapeutics 刚刚宣布为 50 筹款数百万美元。 (公布2024五月25号).
生物技术 行业的其他推荐联系人
消息
Harpoon Therapeutics 的最新新闻稿
- Harpoon Therapeutics to Participate in the Cantor Virtual Global Healthcare Conference | Harpoon Therapeutics, Inc.
- Harpoon Therapeutics to Participate in Two Upcoming Virtual Conferences | Harpoon Therapeutics, Inc.
- Harpoon Therapeutics Names Karin Ann Thacker, M.Sc., VP Regulatory Affairs and Quality Assurance | Harpoon Therapeutics, Inc.
- Harpoon Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update | Harpoon Therapeutics, Inc.
- Harpoon Therapeutics Announces Changes to Board of Directors | Harpoon Therapeutics, Inc.
- Harpoon Therapeutics Updates Information for its Participation in Two Upcoming Virtual Conferences | Harpoon Therapeutics, Inc.
- Harpoon Therapeutics to Participate in Two Upcoming Virtual Conferences | Harpoon Therapeutics, Inc.
- Harpoon Therapeutics Presents Interim Phase 1 Data from an Ongoing Dose Escalation Trial for the PSMA-targeting TriTAC® HPN424 at the ASCO20 Virtual Scientific Program | Harpoon Therapeutics, Inc.
- Harpoon Therapeutics Doses First Patient with HPN217, a BCMA Targeting TriTAC, for Multiple Myeloma | Harpoon Therapeutics, Inc.
- Harpoon Therapeutics Appoints Two New Members to Its Board of Directors | Harpoon Therapeutics, Inc.
- View more press releases Close
通过电子邮件
